Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT03785873 · COMPLETED
Trial details
- NCT number
- NCT03785873
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2024-11-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.